What is the difference between an experiment and a clinical trial?

Experiment (refer to submission package and procedure for Experiments) An experiment is defined as “Every clinical trial, study or research performed on humans, with the intention to gain knowledge inherent to the execution of healthcare professions as defined in Royal Decree n ° 78 of Novembe...
Posted in FAQ

What is a biospecimen?

Human biospecimens are defined as any biological material taken from a human individual for diagnostic or research purposes.  Some examples are: Tissues (skin, tumours, bone,…) Cells Fluids (blood, cerebral spinal fluid, urine, saliva,…) 
Posted in FAQ

What is a biobank?

According to TIME magazine in 2009, biobanks were one of the ten things that were predicted to change the world that year1.A biobank is defined as “a facility for the collection, preservation, storage and supply of biological specimens and associated data, which follows standardized operating p...
Posted in FAQ

End of trial reporting: who is responsible?

End of trial (i.e. the last visit of the last patient – LPLV) needs to be reported to HIRUZ CTU. HIRUZ CTU, when contacted by the investigator with regard to the end of trial, will report the end of trial to the EC and FAMHP.
Posted in FAQ

Do I need to prepare a final report?

Within a year after the end of trial (i.e. the last visit of the last patient) a final study report has to be submitted to the EC and FAMHP, either as a report/summary or as a publication. HIRUZ CTU will contact the investigator with regard to the final report preparation.
Posted in FAQ